Eligibility Lymphoma, Large B-Cell, Diffuse NCT01156259

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy-proved diffuse large b cell lymphoma
Description

Diffuse Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0079744
nonbulky stage i, nonbulky stage ie, nonbulky stage ii, or nonbulky stage iie disease(bulky disease was defined as a mass 10 cm or more in maximal diameter) according to ann arbor staging
Description

Disease Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0432516
provide written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
complete regression after chemotherapy
Description

Disease regression Complete Post Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0684320
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C0687676
UMLS CUI [1,4]
C0392920
considerable to ct simulation and 3d crt or imrt
Description

Consideration CT simulation | Consideration Chemoradiotherapy Three-dimensional | Consideration IMRT

Data type

boolean

Alias
UMLS CUI [1,1]
C0518609
UMLS CUI [1,2]
C0040405
UMLS CUI [1,3]
C0009609
UMLS CUI [2,1]
C0518609
UMLS CUI [2,2]
C0436307
UMLS CUI [2,3]
C0450363
UMLS CUI [3,1]
C0518609
UMLS CUI [3,2]
C1512814
performance status 0-2 who criteria;life expectation>6 months
Description

WHO performance status scale | Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C1298650
UMLS CUI [2]
C0023671
negative for human immunodeficiency virus syndrome (hiv)
Description

HIV syndrome Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C1868990
UMLS CUI [1,2]
C1513916
minimal staging included chest radiograph, computed tomography of the abdomen and pelvis, and single percutaneous bone marrow biopsy and blood studies
Description

Ann Arbor lymphoma staging system | Plain chest X-ray | CT of abdomen | CT of Pelvis | Percutaneous biopsy of bone marrow | Hematologic Tests

Data type

boolean

Alias
UMLS CUI [1]
C0432516
UMLS CUI [2]
C0039985
UMLS CUI [3]
C0412620
UMLS CUI [4]
C0412628
UMLS CUI [5]
C0842622
UMLS CUI [6]
C0018941
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
primary mediastinal large b cell lymphoma
Description

Mediastinal (Thymic) Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C1292754
dermatological lymphoma
Description

Cutaneous lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C1276146
testicular lymphoma
Description

Malignant lymphoma of testis

Data type

boolean

Alias
UMLS CUI [1]
C0349644
primary central nerve system lymphoma
Description

Primary central nervous system lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0280803
prior rt
Description

Prior Radiation Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279134
history of low-grade lymphoma congestive
Description

Lymphoma Congestive Low Grade

Data type

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0742742
UMLS CUI [1,3]
C1282907
history of heart failure (chf; new york heart association [nyha] classifications iii-iv), history of neoplasm (adequately treated basal cell carcinoma of the skin or in situ carcinoma of the uterine cervix were allowed), abnormal liver function tests (aminotransferases and alkaline phosphatase > 2.5 times the upper limit of normal, bilirubin > 50 ), renal insufficiency (serum creatinine > 300 ), and patients with any serious medical or psychiatric illness that would prevent informed consent or completion of protocol-prescribed treatment and follow-up
Description

Heart failure | Congestive heart failure New York Heart Association Classification | Cancer Other | Exception Basal cell carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Liver function tests abnormal finding | Transaminases increased | Alkaline phosphatase raised | Serum total bilirubin measurement | Renal Insufficiency | Creatinine measurement, serum | Illness Serious Preventing Informed Consent | Mental disorders Serious Preventing Informed Consent | Illness Serious Preventing Protocol Compliance | Mental disorders Serious Preventing Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C1275491
UMLS CUI [3]
C1707251
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0851140
UMLS CUI [5,3]
C1522326
UMLS CUI [6]
C0151766
UMLS CUI [7]
C0438717
UMLS CUI [8]
C0151849
UMLS CUI [9]
C1278039
UMLS CUI [10]
C1565489
UMLS CUI [11]
C0201976
UMLS CUI [12,1]
C0221423
UMLS CUI [12,2]
C0205404
UMLS CUI [12,3]
C1292733
UMLS CUI [12,4]
C0021430
UMLS CUI [13,1]
C0004936
UMLS CUI [13,2]
C0205404
UMLS CUI [13,3]
C1292733
UMLS CUI [13,4]
C0021430
UMLS CUI [14,1]
C0221423
UMLS CUI [14,2]
C0205404
UMLS CUI [14,3]
C1292733
UMLS CUI [14,4]
C0525058
UMLS CUI [15,1]
C0004936
UMLS CUI [15,2]
C0205404
UMLS CUI [15,3]
C1292733
UMLS CUI [15,4]
C0525058

Similar models

Eligibility Lymphoma, Large B-Cell, Diffuse NCT01156259

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse Large B-Cell Lymphoma
Item
biopsy-proved diffuse large b cell lymphoma
boolean
C0079744 (UMLS CUI [1])
Disease Ann Arbor lymphoma staging system
Item
nonbulky stage i, nonbulky stage ie, nonbulky stage ii, or nonbulky stage iie disease(bulky disease was defined as a mass 10 cm or more in maximal diameter) according to ann arbor staging
boolean
C0012634 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
Informed Consent
Item
provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Disease regression Complete Post Chemotherapy
Item
complete regression after chemotherapy
boolean
C0684320 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
Consideration CT simulation | Consideration Chemoradiotherapy Three-dimensional | Consideration IMRT
Item
considerable to ct simulation and 3d crt or imrt
boolean
C0518609 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0009609 (UMLS CUI [1,3])
C0518609 (UMLS CUI [2,1])
C0436307 (UMLS CUI [2,2])
C0450363 (UMLS CUI [2,3])
C0518609 (UMLS CUI [3,1])
C1512814 (UMLS CUI [3,2])
WHO performance status scale | Life Expectancy
Item
performance status 0-2 who criteria;life expectation>6 months
boolean
C1298650 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
HIV syndrome Negative
Item
negative for human immunodeficiency virus syndrome (hiv)
boolean
C1868990 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
Ann Arbor lymphoma staging system | Plain chest X-ray | CT of abdomen | CT of Pelvis | Percutaneous biopsy of bone marrow | Hematologic Tests
Item
minimal staging included chest radiograph, computed tomography of the abdomen and pelvis, and single percutaneous bone marrow biopsy and blood studies
boolean
C0432516 (UMLS CUI [1])
C0039985 (UMLS CUI [2])
C0412620 (UMLS CUI [3])
C0412628 (UMLS CUI [4])
C0842622 (UMLS CUI [5])
C0018941 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Mediastinal (Thymic) Large B-Cell Lymphoma
Item
primary mediastinal large b cell lymphoma
boolean
C1292754 (UMLS CUI [1])
Cutaneous lymphoma
Item
dermatological lymphoma
boolean
C1276146 (UMLS CUI [1])
Malignant lymphoma of testis
Item
testicular lymphoma
boolean
C0349644 (UMLS CUI [1])
Primary central nervous system lymphoma
Item
primary central nerve system lymphoma
boolean
C0280803 (UMLS CUI [1])
Prior Radiation Therapy
Item
prior rt
boolean
C0279134 (UMLS CUI [1])
Lymphoma Congestive Low Grade
Item
history of low-grade lymphoma congestive
boolean
C0024299 (UMLS CUI [1,1])
C0742742 (UMLS CUI [1,2])
C1282907 (UMLS CUI [1,3])
Heart failure | Congestive heart failure New York Heart Association Classification | Cancer Other | Exception Basal cell carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Liver function tests abnormal finding | Transaminases increased | Alkaline phosphatase raised | Serum total bilirubin measurement | Renal Insufficiency | Creatinine measurement, serum | Illness Serious Preventing Informed Consent | Mental disorders Serious Preventing Informed Consent | Illness Serious Preventing Protocol Compliance | Mental disorders Serious Preventing Protocol Compliance
Item
history of heart failure (chf; new york heart association [nyha] classifications iii-iv), history of neoplasm (adequately treated basal cell carcinoma of the skin or in situ carcinoma of the uterine cervix were allowed), abnormal liver function tests (aminotransferases and alkaline phosphatase > 2.5 times the upper limit of normal, bilirubin > 50 ), renal insufficiency (serum creatinine > 300 ), and patients with any serious medical or psychiatric illness that would prevent informed consent or completion of protocol-prescribed treatment and follow-up
boolean
C0018801 (UMLS CUI [1])
C0018802 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
C1707251 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0851140 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C0151766 (UMLS CUI [6])
C0438717 (UMLS CUI [7])
C0151849 (UMLS CUI [8])
C1278039 (UMLS CUI [9])
C1565489 (UMLS CUI [10])
C0201976 (UMLS CUI [11])
C0221423 (UMLS CUI [12,1])
C0205404 (UMLS CUI [12,2])
C1292733 (UMLS CUI [12,3])
C0021430 (UMLS CUI [12,4])
C0004936 (UMLS CUI [13,1])
C0205404 (UMLS CUI [13,2])
C1292733 (UMLS CUI [13,3])
C0021430 (UMLS CUI [13,4])
C0221423 (UMLS CUI [14,1])
C0205404 (UMLS CUI [14,2])
C1292733 (UMLS CUI [14,3])
C0525058 (UMLS CUI [14,4])
C0004936 (UMLS CUI [15,1])
C0205404 (UMLS CUI [15,2])
C1292733 (UMLS CUI [15,3])
C0525058 (UMLS CUI [15,4])